Mectizan Donation Program | Local power. Global Change.
MERCK A program at The Task Force for Global Health
Switch to French site

MDP News & Resources

Looking for specific news & resource articles?
Enter a search phrase, select a category or topic, and click the green search button below.


Lymphatic Filariasis Eliminated in Malawi

28 October 2020

The World Health Organization (WHO) announced in this week’s WHO Weekly Epidemiological Record that Malawi has been validated to have eliminated lymphatic filariasis as a public health problem.

MDP/Merck Grant Application For Supplementary Funding for COVID-19 Mitigation

This is the Mectizan Donation Program and Merck & Co., Inc. grant application to assist non-governmental organization (NGO) partners with resuming mass drug administration by supporting implementation of COVID-19 mitigation strategies.

MDP/Merck Grant Application For Supplementary Funding for COVID-19 Mitigation (139.68 KB)

Annual Highlights

2019 Mectizan Donation Program Annual Highlights (English)

These are the accomplishments of the Mectizan Donation Program and its partners in 2019.

MDP Annual Highlights 2019 (English) (8.27 MB)

Annual Highlights

2019 Mectizan Donation Program Annual Highlights (French)

These are the accomplishments of the Mectizan Donation Program and its partners in 2019.

MDP Annual Highlights 2019 (French) (9.08 MB)

MDP Publication: Building country capacity to sustain NTD programs and progress: A call to action

This research article, co-authored by MDP’s Yao Sodahlon and Joni Lawrence, Merck’s Rachel Taylor, The Task Force for Global Health’s CEO, Dave Ross, and many NTD program managers, is focused on the need for building country capacity by increasing country ownership and domestic spending for NTD programs.

Sodahlon et al., 2020 (453.99 KB)


PAHO Recommendation regarding the use of Ivermectin as a treatment for COVID-19

A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications on observational clinical studies reported the apparent utility of ivermectin to treat patients with COVID-19 needing mechanical ventilation; neither of these studies were peer-reviewed nor formally published and one of them was later retracted.

PAHO Recommendation Regarding the Use of Ivermectin as a Treatment for COVID-19 (381.44 KB)


Video of microfilariae in the anterior chamber of the eye

This is footage[1] of microfilariae was captured in a 59-year-old man’s anterior chamber of the eye. The man lives in an onchocerciasis-endemic area in eastern Ghana.

Appearance of Mf in the anterior chamber (25.87 MB)


MDP’s Commitment to WHO’s Road Map 2021 – 2030

The Mectizan Donation Program is committed to working towards WHO’s NTD Road Map 2030 targets and the path towards eliminating river blindness and lymphatic filariasis.


Stamp Out Oncho – A Community Drug Distributor’s Dedication On Distribution

This short film covers the dedication of a community drug distributor on working towards eliminating onchocerciasis (river blindness) in Cameroon, Africa.

Scientific Publication

Publication: Low transmission of Wuchereria bancrofti in cross-border districts of Côte d’Ivoire: A great step towards lymphatic filariasis elimination in West Africa

This research article focuses on the results of four rounds of mass drug administration (MDA) for cross-border districts of Côte d’Ivoire where lymphatic filariasis (LF) is endemic.

Yokoly et al., 2020 (1.05 MB)

Scientific Publication

Publication: Post-Treatment Surveillance for Lymphatic Filariasis in Plateau and Nasarawa States, Nigeria: Results of Transmission Assessment Surveys

In order to confirm that transmission recrudescence or importation does not occur for lymphatic filariasis (LF) after mass drug administration (MDA), the WHO recommends post-treatment surveillance.

Eigege et al., 2020 (321.96 KB)

Scientific Publication

Publication: Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé foci, Mali

This research article examines the Ov16 (onchocerciasis) and Wb123 (lymphatic filariasis) seroprevalence in the Bakoye and Falémé foci in Mali after 24 – 25 years of treatment.

Dolo et al., 2020 (1.05 MB)


Stamp Out Oncho – Cameroon 2019 (A Short Film)

This short film covers the movement to eliminate Onchocerciasis (river blindness) in Cameroon, Africa. Follow our Vimeo account for more video footage from the field.

Scientific Publication

Publication: Challenges to Making the Decision to Stop Mass Drug Administration for Onchocerciasis: Lessons Learned from Nigeria

This editorial from Darin S. Evans raises important questions regarding the decision to stop mass drug administration (MDA) for countries with onchocerciasis as they approach transmission interruption.

Evans, 2020 (38.33 KB)

WHO Guide

WHO Road Map 2021-2030: Ending the Neglect to Attain the Sustainable Development Goals (draft)

The WHO road map for neglected tropical diseases (NTDs) is a call to action for Member States, donors, implementing partners, disease experts and all other stakeholders to align their strategies and plans towards the prevention of infections and alleviation of the suffering of people affected by NTDs.

WHO Road Map for NTDs 2021-2030 (2.45 MB)

Scientific Publication

Publication: Interruption of Transmission of Human Onchocerciasis by Mass Drug Administration Program in Plateau & Nasarawa States, Nigeria

This research paper focuses on the first stop-Mass Drug Administration (MDA) decision for onchocerciasis in Nigeria. These findings can be modeled by other African countries to advance their MDA programs to reach similar levels of success.

Richards et al., 2020 (803.37 KB)

Scientific Publication

Publication: The First Coordinated Interruption of Onchocerciasis Transmission in Africa

This research paper details the coordinated stop of MDA, decided by Sudan and Ethiopia, due to satisfying the World Health Organization’s criteria for interruption of onchocerciasis transmission.

Katabarwa et al., 2020 (3.04 MB)